CWA Asset Management Group LLC lifted its holdings in UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 0.3% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,646 shares of the healthcare conglomerate’s stock after buying an additional 35 shares during the period. CWA Asset Management Group LLC’s holdings in UnitedHealth Group were worth $6,959,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. NorthCrest Asset Management LLC boosted its position in shares of UnitedHealth Group by 9.5% during the 1st quarter. NorthCrest Asset Management LLC now owns 518 shares of the healthcare conglomerate’s stock valued at $264,000 after acquiring an additional 45 shares during the last quarter. Domani Wealth LLC grew its stake in shares of UnitedHealth Group by 0.7% in the 1st quarter. Domani Wealth LLC now owns 3,542 shares of the healthcare conglomerate’s stock valued at $1,806,000 after buying an additional 25 shares during the period. Lincoln National Corp grew its position in UnitedHealth Group by 15.1% in the fourth quarter. Lincoln National Corp now owns 8,951 shares of the healthcare conglomerate’s stock worth $4,495,000 after acquiring an additional 1,174 shares during the period. Salvus Wealth Management LLC raised its position in UnitedHealth Group by 23.5% in the first quarter. Salvus Wealth Management LLC now owns 782 shares of the healthcare conglomerate’s stock valued at $399,000 after purchasing an additional 149 shares during the period. Finally, YorkBridge Wealth Partners LLC increased its position in shares of UnitedHealth Group by 1.8% during the 4th quarter. YorkBridge Wealth Partners LLC now owns 15,296 shares of the healthcare conglomerate’s stock worth $7,681,000 after purchasing an additional 272 shares during the last quarter. 87.48% of the stock is owned by institutional investors.
A number of equity research analysts have recently issued reports on UNH shares. Oppenheimer boosted their price target on shares of UnitedHealth Group from $550.00 to $600.00 and gave the company an “outperform” rating in a research note on Monday, April 18th. SVB Leerink raised their price target on UnitedHealth Group from $550.00 to $600.00 and gave the stock an “outperform” rating in a research report on Tuesday, April 19th. Raymond James increased their target price on UnitedHealth Group from $540.00 to $620.00 and gave the stock a “strong-buy” rating in a research note on Tuesday, April 19th. Sanford C. Bernstein lowered shares of UnitedHealth Group from an “outperform” rating to a “market perform” rating and set a $561.00 target price on the stock. in a report on Thursday, May 26th. They noted that the move was a valuation call. Finally, Deutsche Bank Aktiengesellschaft raised their price objective on UnitedHealth Group from $482.00 to $549.00 and gave the stock a “buy” rating in a research report on Monday, April 18th. Three equities research analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat, UnitedHealth Group has a consensus rating of “Moderate Buy” and a consensus price target of $555.73.
In related news, EVP Erin Mcsweeney sold 1,273 shares of the stock in a transaction dated Thursday, June 23rd. The stock was sold at an average price of $499.00, for a total transaction of $635,227.00. Following the transaction, the executive vice president now directly owns 8,104 shares in the company, valued at $4,043,896. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Richard T. Burke sold 2,500 shares of the business’s stock in a transaction on Thursday, May 19th. The shares were sold at an average price of $478.96, for a total transaction of $1,197,400.00. Following the sale, the director now directly owns 1,215,000 shares of the company’s stock, valued at $581,936,400. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 6,273 shares of company stock valued at $3,065,752. 0.40% of the stock is currently owned by company insiders.
UNH stock opened at $517.40 on Monday. UnitedHealth Group Incorporated has a 12 month low of $383.12 and a 12 month high of $553.29. The company has a debt-to-equity ratio of 0.54, a current ratio of 0.78 and a quick ratio of 0.78. The company has a market cap of $485.41 billion, a price-to-earnings ratio of 28.32, a price-to-earnings-growth ratio of 1.61 and a beta of 0.77. The company has a fifty day moving average price of $492.77 and a 200 day moving average price of $492.61.
UnitedHealth Group (NYSE:UNH – Get Rating) last posted its quarterly earnings data on Thursday, April 14th. The healthcare conglomerate reported $5.49 earnings per share for the quarter, beating analysts’ consensus estimates of $5.40 by $0.09. The firm had revenue of $80.15 billion for the quarter, compared to analyst estimates of $78.77 billion. UnitedHealth Group had a net margin of 5.86% and a return on equity of 24.74%. UnitedHealth Group’s quarterly revenue was up 14.2% on a year-over-year basis. During the same period last year, the firm posted $5.31 EPS. As a group, analysts anticipate that UnitedHealth Group Incorporated will post 21.75 earnings per share for the current year.
The company also recently announced a quarterly dividend, which was paid on Tuesday, June 28th. Shareholders of record on Monday, June 20th were given a dividend of $1.65 per share. This represents a $6.60 dividend on an annualized basis and a yield of 1.28%. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.45. The ex-dividend date was Thursday, June 16th. UnitedHealth Group’s payout ratio is currently 36.12%.
About UnitedHealth Group: (Get Rating)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments. UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic diseases and other specialized issues for older individuals; Medicaid plans, children’s health insurance and health care programs; health and dental benefits; and hospital and clinical services.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Get Rating).
Receive News & Ratings for UnitedHealth Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for UnitedHealth Group and related companies with MarketBeat.com’s FREE daily email newsletter.